Skip to main content
Have a personal or library account? Click to login
Current Aspects of Epidemiology, Pathogenesis and Treatment in Diabetic Macular Edema Cover

Current Aspects of Epidemiology, Pathogenesis and Treatment in Diabetic Macular Edema

Open Access
|Apr 2011

References

  1. Antcliff RJ, Marshall J. The pathogenesis of edema in diabetic maculopathy // Semin Ophthalmol., 1999;14:223-232
  2. Bhagat N, Grigorian RA and Tutela A. Diabetic macular edema: pathogenesis and treatment // Survey of Ophthalmology, 2009; 54: 1-3210.1016/j.survophthal.2008.10.001
  3. Cunha-Vaz J. G. Pathophysiology of diabetic retinopathy // British Joiurnial of Ophlthalmology, 1978; 62, 351-35510.1136/bjo.62.6.351
  4. Donald R. Senger. Vascular Endothelial Growth Factor: Much More than an Angiogenesis Factor // Molecular Biology of the Cell, 2010; 21(3): 377-379
  5. Early Treatment Diabetic Retinopathy Study Research Group. Photocoagulation for diabetic macular edema: ETDRS report no. 4. // Int Ophthalmol Clin, 1987; 27:265-7210.1097/00004397-198702740-00006
  6. Engler CB, Sander B, Larsen M, Koefoed P, Parving HH, Lund-Andersen H. Probenecid inhibition of the outward transport of fluorescein across the human blood-retina barrier // Acta Ophthalmol (Copenh), 1994; 72:663-667.10.1111/j.1755-3768.1994.tb04676.x
  7. Hans-Peter Hammes, Jihong Lin, Oliver Renner, Moshe Shani, Andrea Lundqvist, Christer Betsholtz, Michael Brownlee, and Urban Deutsch. Pericytes and the Pathogenesis of Diabetic Retinopathy // Diabetes, 2002; 51(10):3107-1210.2337/diabetes.51.10.3107
  8. Kang SW, Park CY, Ham DI. The correlation between fluorescein angiographic and optical coherence tomographic features in clinically significant diabetic macular edema // Am J Ophthalmol., 2004; 137(2):313-22
  9. Klein R, Klein B, Moss S, Davis M, DeMets D. The Wisconsin Epidemiologic Study of Diabetic Retinopathy, IV: diabetic macular edema // Ophthalmology, 1984; 91:1464-147410.1016/S0161-6420(84)34102-1
  10. Koyano S, Araie M, Eguchi S. Movement of fluorescein and its glucuronide across retinal pigment epithelium-choroid // Invest Ophthalmol Vis Sci, 1993; 34:531-538.
  11. Martidis A, Duker JS, Greenberg PB, Rogers AH, Puliafito CA, Reichel E, Baumal C. Intravitreal triamcinolone for refractory diabetic macular edema // Ophthalmology, 2002 May; 109(5):920-710.1016/S0161-6420(02)00975-2
  12. Mokdad AH, Ford ES, Bowman BA, Nelson DE, Engelgau MM, Vinicor F, Marks JS. Diabetes trends in the U. S.: 1990-1998 // Diabetes Care, 2000; 23:1278-1283
  13. Moss S, Klein R, Klein B. The 14-year incidence of visual loss in a diabetic population // Ophthalmology, 1998; 105:998-100310.1016/S0161-6420(98)96025-0
  14. Moss SE, Klein R and Klein BE. The 14-year incidence of visual loss in diabetic population // Ophthalmology, 1995; 97: 415-419
  15. Negi A and Vernon SA. An overview of the eye in diabetes // Journal of the Royal Society of Medicine, 2003; 96:266-27210.1177/014107680309600603
  16. Nguyen QD, Tatlipinar S, Shah SM, Haller JA, Quinlan E, Sung J, Zimmer-Galler I, Do DV, Campochiaro PA. Vascular endothelial growth factor is a critical stimulus for diabetic macular edema // Am J Ophthalmol, 2006;142(6): 961-910.1016/j.ajo.2006.06.06817046701
  17. Pendergast SD, Hassan TS, Williams GA, Cox MS, Margherio RR, Ferrone PJ, Garretson BR, Trese MT. Vitrectomy for diffuse diabetic macular edema associated with a taut premacular posterior hyaloid // Am J Ophthalmol, 2000; 130(2):178-8610.1016/S0002-9394(00)00472-4
  18. Peter Kroll, Marburg. Current Aspects of Pathogenesis and Treatment in Diabetic Retinopathy // Ophthalmologica 2007; 221:7710.1159/isbn.978-3-318-01449-5
  19. PKC-DRS2 Group, Aiello LP, Davis MD, Girach A, Kles KA, Milton RC, Sheetz MJ, Vignati L, Zhi XE. Effect of ruboxistaurin on visual loss in patients with diabetic retinopathy // Ophthalmology, 2006;113(12):2221-3010.1016/j.ophtha.2006.07.032
  20. Rosenfeld PJ, Moshfeghi AA, Puliafito CA. Optical coherence tomography findings after an intravitreal injection of bevacizumab (Avastin) for neovascular age-related macular degeneration // Ophthalmic Surg Lasers Imaging. 2005; 36:331-33510.3928/1542-8877-20050701-14
  21. Sander B, Larsen M, Moldow B, Lund-Andersen H. Diabetic macular edema: passive and active transport of fluorescein through the blood-retina barrier // Invest Ophthalmol Vis Sci 2001;42: 433-438.
  22. Schepens CL, Avila MP, Jalkh AE, Trempe CL. Role of the vitreous in cystoid macular edema // Surv Ophthalmol, 1984; 28(suppl):499-504.10.1016/0039-6257(84)90232-7
  23. Tolentino MJ, Miller JW, Gragoudas ES, et al. Intravitreous injections of vascular endothelial growth factor produce retinal ischemia and microangiopathy in an adult primate // Ophthalmology 1996; 103: 1820-8.10.1016/S0161-6420(96)30420-X
  24. Treatment Diabetic Retinopathy Study Research Group. Photocoagulation for diabetic macular edema: Early Treatment Diabetic Retinopathy Study report number 1. // Arch Ophthalmol 1985; 103:1796-80610.1001/archopht.1985.01050120030015
  25. Vinores S, Youssri A, Luna J, et al. Upregulation of vascular endothelial growth factor in ischemic and non-ischemic human and experimental retinal disease // Histol Histopathol 1997; 12:99-109
DOI: https://doi.org/10.2478/v10163-011-0019-8 | Journal eISSN: 2199-5737 (formerly 1407-981X) | Journal ISSN: 1407-981X
Language: English
Page range: 98 - 101
Published online: Apr 7, 2011
Published in print: Jan 1, 2010
Published by: Riga Stradins University
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year

© 2011 Indars Lacis, Igors Solomatins, Jana Gertnere, Aida Macijevska, published by Riga Stradins University
This work is licensed under the Creative Commons License.